Sex-Specific Clinical Patterns in Febrile Illness

Abstract

Sex-specific differences in febrile illness have significant implications for clinical practice, influencing presentation, diagnostic strategies, management, and patient outcomes. Recent studies underscore the impact of biological sex on immune response, symptomatology, risk factors, and therapeutic outcomes in a range of infectious and inflammatory conditions. This review synthesizes current evidence on sex-based clinical variations in febrile syndromes, explores underlying mechanisms, and provides guidance for clinicians to optimize individualized care, integrating recent advances and guideline recommendations.

Introduction

Febrile illnesses constitute a major cause of morbidity and healthcare utilization worldwide. The clinical approach to fever is shaped by an array of host and pathogen factors, including age, comorbidities, and crucially, biological sex. Growing evidence highlights that males and females may exhibit differing patterns in susceptibility, disease course, and response to therapy across various febrile conditions. Recognizing and understanding these sex-specific clinical patterns is essential for tailoring patient assessment and management, improving diagnostic accuracy, and optimizing outcomes in both acute and chronic febrile syndromes.

Epidemiology / Disease Burden

Sex-based disparities in the epidemiology of febrile illnesses are evident in both community and hospital settings. Epidemiological data demonstrate that males generally experience higher rates of certain bacterial infections, such as sepsis and pneumonia, particularly in adulthood, whereas females may have higher incidence of autoimmune-related febrile syndromes and viral infections during specific life stages. For example, urinary tract infections (UTIs) are significantly more prevalent in females, especially during reproductive years, while males demonstrate increased risk of severe outcomes in systemic infections. These differences are compounded by sociocultural factors, healthcare-seeking behaviors, and access to care, contributing to variable disease burden and outcome profiles between sexes.

Pathophysiology

The pathophysiological basis for sex-specific differences in febrile illness lies in the complex interplay between genetic, hormonal, and immunological factors. Females generally mount a more robust innate and adaptive immune response, largely attributed to estrogen-mediated modulation of immune cell function and expression of immune-related genes on the X chromosome. Conversely, androgens such as testosterone exert immunosuppressive effects, contributing to higher susceptibility and severity of infection in males. These hormonal influences affect cytokine release, fever generation, and pathogen clearance. Additionally, sex-based differences in microbiome composition and metabolic pathways further modulate host response to infectious stimuli.

Risk Factors

Risk factors for febrile illnesses demonstrate notable sex-specific patterns. In females, pregnancy, use of hormonal contraceptives, and higher rates of autoimmune disorders increase vulnerability to certain infections and inflammatory conditions. Anatomical differences, such as shorter urethra in females, predispose to UTIs. In males, comorbidities like diabetes, alcoholism, and cardiovascular disease are more prevalent and contribute to increased risk and severity of febrile illnesses. Behavioral factors, including occupational exposures and lifestyle choices, also differentially impact risk profiles between sexes, necessitating tailored preventive strategies.

Clinical Features

Clinical presentation of febrile illness can vary significantly by sex. Studies report that females are more likely to present with atypical symptoms, such as generalized malaise or non-specific pain, while males often manifest classic signs like rigors and high fevers. In conditions such as endocarditis and sepsis, males may have a more fulminant presentation and worse prognosis, whereas females may present later and with subtler features. Hormonal fluctuations, particularly during menstrual cycles or pregnancy, can modulate symptom severity and fever threshold in females. Recognizing these nuanced differences is critical to avoid misdiagnosis or delayed intervention.

Diagnosis

Diagnostic approaches to febrile illness must account for sex-specific variation in clinical and laboratory parameters. Reference ranges for inflammatory markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), may differ by sex, influencing interpretation of results. Imaging modalities and microbiological testing should be guided by sex-specific anatomical and physiological considerations, such as pelvic ultrasonography in females with fever of unknown origin. Awareness of sex-based differences in symptomatology can direct more focused diagnostic workups, reducing unnecessary testing and improving efficiency.

Treatment & Management

Sex influences pharmacokinetics and pharmacodynamics of antipyretics, antibiotics, and adjunctive therapies, necessitating dose adjustments and careful monitoring. Females are at higher risk for certain adverse drug reactions, such as QT prolongation with macrolide antibiotics, while males may be more prone to hepatic toxicity from some antipyretics. Hormonal status, pregnancy, and lactation further complicate management decisions in females. Evidence supports individualized treatment regimens, incorporating sex-specific factors to maximize therapeutic efficacy and minimize harm.

Recent Advances / Emerging Therapies

Recent research highlights the potential of sex-specific biomarkers and personalized medicine approaches in the management of febrile illnesses. Advances in genomics and proteomics have identified novel pathways through which sex hormones modulate immune responses, offering targets for future therapeutic interventions. Clinical trials increasingly stratify outcomes by sex, revealing differential responses to immunomodulatory agents and vaccines. Artificial intelligence and machine learning models now incorporate sex as a variable to enhance diagnostic accuracy and predict outcomes in febrile syndromes.

Guideline Recommendations

Major clinical guidelines, including those from the Infectious Diseases Society of America (IDSA) and World Health Organization (WHO), increasingly recognize the importance of sex-specific considerations in the evaluation and management of febrile illness. Recommendations emphasize individualized risk assessment, attention to sex-based variations in presentation, and tailored therapeutic strategies. Ongoing updates to guidelines are incorporating emerging evidence on sex differences in disease pathophysiology and treatment outcomes, supporting the move toward precision medicine in infectious disease care.

Conclusion

Sex-specific clinical patterns in febrile illness are underpinned by complex biological, hormonal, and sociocultural factors, profoundly impacting diagnostic and management strategies. A nuanced understanding of these differences enables clinicians to provide more precise, effective, and equitable care for patients presenting with fever. As research continues to elucidate the mechanisms driving sex-based disparities, integration of this knowledge into clinical practice and guideline development will be crucial for improving patient outcomes and advancing the field of infectious diseases.